Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTNT.L Regulatory News (TNT)

  • There is currently no data for TNT

Update on Funding Round

30 Nov 2022 15:31

RNS Number : 1281I
Tintra PLC
30 November 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

 

30 November 2022

TINTRA PLC

 ("Tintra", the "Group" or the "Company")

 

Funding Round

 

The board of directors of Tintra (the "Board") is pleased to provide an update on the Company's fundraising plans, previously set out in the Company's most recent annual report as well as the Company's business update, as announced on 8 November 2022.

 

The Board has presented to certain High Net Worth Investors and Family Offices and received non-binding commitments for the raise that are now in negotiations to finalise terms (although there can be no guarantee that these will be successfully finalised). Notwithstanding the Company previously expecting to complete the funding round in November 2022, it is the Board view that progress in respect of the fundraising is proceeding in a positive manner. 

 

It is the Board's intention to raise circa US$25m during the current round (the "Funding Round"), with the first tranche of at least US$10m expected to be closed during the first two weeks of December 2022, and the balance before the end of the Company's financial year (31 January 2023).

 

In line with previous announcements by the Company, it is the Board's intention that the Funding Round will be priced so that the US$25m of new shares to be issued to be the equivalent of 10% of the enlarged ordinary share capital of the Company.

 

It is emphasised that the Funding Round is, amongst other matters, subject to ongoing negotiation and therefore there can be no certainty that the Funding Round will proceed in line with the terms previously outlined by the Company.

 

Further announcements will be made at the appropriate time.

 

For further information, contact:

 

Tintra PLC

(Communications Head)

Hannah Haffield

h.haffield@tintra.com

Website www.tintra.com

020 3795 0421

 

Allenby Capital Limited

(Nomad, Financial Adviser & Broker)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

020 3328 5656

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFDSFISEESEDF
Date   Source Headline
2nd Jun 20237:00 amRNSTotal Voting Rights & Licence Update
25th May 20232:17 pmRNSUpdate on UK Licence Application
23rd May 20239:38 amRNSReplacement - Director/PDMR Shareholding
16th May 20232:00 pmRNSNew Patent Applications
5th May 202312:32 pmRNSUpdate in relation to the Placement Facility
4th May 20237:00 amRNSConversion of Loan Stock and Total Voting Rights
6th Apr 20231:08 pmRNSRepayment Under Placement Facility
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 202311:55 amRNSParticipation in the Call to Advance Democracy
30th Mar 20233:00 pmRNSDirector/PDMR Shareholding
17th Mar 20232:15 pmRNSDirector/PDMR Shareholding
13th Mar 20233:07 pmRNSNotification of US Patent to Protect Web3 IP
10th Mar 202310:30 amRNSStrategic investment under current funding round
9th Mar 20237:00 amRNSKey Management Appointment & Directorate Change
8th Mar 20239:30 amRNSTintra to establish new hub in Rwanda
3rd Feb 20237:00 amRNSKey Management Appointment
2nd Feb 202311:00 amRNSUpdate on US Patent Applications
30th Jan 20237:45 amRNSIssue of Ordinary Shares Under Funding Round
25th Jan 20237:00 amRNSAppointment of Chief Operating Officer
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSTotal Voting Rights
21st Dec 20221:00 pmRNSHolding(s) in Company
16th Dec 20227:30 amRNSUS$10,000,000 Placement Facility
16th Dec 20227:00 amRNSStrategic Investment Under Current Funding Round
30th Nov 20223:31 pmRNSUpdate on Funding Round
8th Nov 20229:00 amRNSIssue of Convertible Loan Notes & PCA Holding
8th Nov 20227:30 amRNSBusiness Update
27th Oct 20227:00 amRNSHalf-year Report to 31 July 2022
18th Oct 202212:00 pmRNSUpdate on PPS Asset Realisation Co Limited
4th Oct 202212:00 pmRNSTotal Voting Rights
27th Sep 20227:00 amRNSUpdate on PPS Asset Realisation Co Limited
22nd Sep 20227:00 amRNSAppointment of Chief Innovation Officer
21st Sep 20226:00 pmRNSExercise of Options & Conversion Rights
21st Sep 202211:05 amRNSResult of Adjourned AGM
14th Sep 202210:30 amRNSGranting of Middle East Licence
14th Sep 20227:00 amRNSContract with Temenos for Core Banking Software
24th Aug 202210:30 amRNSNotice of Reconvening of AGM & Supplementary Note
1st Aug 20227:00 amRNSFinal Results & Annual Report for Yr to 31 Jan 22
29th Jul 202210:36 amRNSResult of AGM
29th Jul 20227:00 amRNSAGM Statement
11th Jul 20222:00 pmRNSUS Patent Application Filings to Protect Web3 IP
7th Jul 20227:00 amRNSFiling of UK Patent Application & Notice of AGM
28th Jun 20227:00 amRNSAI in banking needs to be 'explainable'
27th Jun 20227:00 amRNSAppointment of Chief Science Officer
16th Jun 20227:00 amRNSPatent Application
15th Jun 20227:00 amRNSWestern banks prefer metaverse to emerging markets
8th Jun 20227:00 amRNSThe importance of financial inclusion
20th May 20227:00 amRNSBusiness Update
29th Apr 20225:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.